ENvue Medical (FEED) Shareholder's Equity Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.03% |
| Dec 31, 2025 | 118.01% |
| Sep 30, 2025 | 137.90% |
| Jun 30, 2025 | 113.93% |
| Mar 31, 2025 | 89.28% |
| Dec 31, 2024 | -53.69% |
| Sep 30, 2024 | -40.10% |
| Jun 30, 2024 | -11.97% |
| Mar 31, 2024 | -6.93% |
| Dec 31, 2023 | 18.55% |
| Sep 30, 2023 | 12.81% |
| Jun 30, 2023 | 51.63% |
| Mar 31, 2023 | 64.16% |
| Dec 31, 2022 | 33.89% |
| Sep 30, 2022 | 12.25% |
| Jun 30, 2022 | 28.79% |
| Mar 31, 2022 | 136.44% |
| Dec 31, 2021 | 138.90% |
| Sep 30, 2021 | 84.54% |
| Jun 30, 2021 | 23.33% |
| Mar 31, 2021 | 13.74% |
| Dec 31, 2020 | -12.99% |
| Sep 30, 2020 | 40.30% |
| Jun 30, 2020 | 36.42% |
| Mar 31, 2020 | 29.62% |
| Dec 31, 2019 | 36.42% |
| Sep 30, 2019 | 50.24% |
| Jun 30, 2019 | 54.22% |
| Mar 31, 2019 | 8.19% |
| Dec 31, 2018 | 61.54% |
| Sep 30, 2018 | 40.01% |
| Jun 30, 2018 | 14.68% |
| Mar 31, 2018 | 134.53% |
| Dec 31, 2017 | 38.33% |
| Sep 30, 2017 | 4.45% |
| Jun 30, 2017 | 9.80% |
| Mar 31, 2017 | 9.21% |